Common Side Effects Reported Across Phase 2 trials, participants experienced dose-dependent GI symptoms that are characteristic of GLP-1 receptor agonists: Nausea most frequent, especially during dose escalation Vomiting typically mild to moderate, subsiding with continued use Diarrhea and constipation fluctuating depending on individual tolerance Abdominal discomfort transient and often improved over time Dose-Response Relationship At lower doses (14 mg weekly), side effects were generally mild and manageable, though some participants still reported early GI symptoms
Before beginning any weight loss program, whether it includes weight loss medication or not, be sure to consult with your health care provider to make sure your desired weight loss strategy is right for you
Gojkovic S, Krezic I, Vrdoljak B, Malekinusic D, Barisic I, Petrovic A, et al
A 30mg vial is particularly well-suited for microdosing because it provides a large supply at low dose levels